Supplemental material
Human Vaccines & Immunotherapeutics
Volume 19, 2023 - Issue 1
Licensed Vaccines
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
Peter Van den SteenGSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-7931-1781View further author information
https://orcid.org/0000-0001-7931-1781View further author information, Brigitte CheuvartGSK, Wavre, Belgiumhttps://orcid.org/0000-0001-7156-0062View further author information
https://orcid.org/0000-0001-7156-0062View further author information, Quentin DeraedtGSK, Wavre, Belgiumhttps://orcid.org/0000-0001-9226-2777View further author information
https://orcid.org/0000-0001-9226-2777View further author information, Laura Valdes VerelstGSK, Wavre, Belgiumhttps://orcid.org/0000-0003-1929-8233View further author information
https://orcid.org/0000-0003-1929-8233View further author information & Dasha ShamarinaGSK, Wavre, Belgiumhttps://orcid.org/0000-0002-4622-4224View further author information
https://orcid.org/0000-0002-4622-4224View further author information